e.l.f. Beauty (ELF) Q4 2026 earnings summary

Executive summary

• Achieved seventh consecutive year of industry-leading growth, with net sales up 25% to $1.64B and Adjusted EBITDA up 13% for fiscal 2026, marking 29 consecutive quarters of net sales growth.

• Portfolio diversification accelerated, with non-e.l.f. brands now 30% of global consumption and skincare rising to 23% of mix.

• Rhode and Naturium acquisitions drove significant growth and international expansion, with Rhode contributing $113M in Q4 and Naturium doubling sales to $250M.

• Expanded global retail sales to $1.8B for e.l.f. Cosmetics and $200M for e.l.f. SKIN in FY 2026.

• All five brands experienced growth, with record-breaking international launches and expansion into new categories such as fragrance and haircare.

Financial highlights

• Fiscal 2026 net sales grew 25% year-over-year to $1.64B; Adjusted EBITDA up 13% to $335.2M.

• Q4 net sales up 35% year-over-year to $449.3M, with Rhode contributing $113M.

• Q4 gross margin reached 73%, up 140 basis points from prior year, driven by pricing; full-year gross margin was 71%.

• Q4 adjusted EBITDA was $59M (down from $81M), and adjusted net income was $19M ($0.32 per share); full-year adjusted net income was $185.9M.

• Ended year with $290M cash, up from $149M; repurchased $50M in stock, with $400M remaining under repurchase program.

Outlook and guidance

• Fiscal 2027 net sales expected to grow 12%-14% to $1.84–$1.87B; Adjusted EBITDA $379M-$385M; Adjusted EPS $3.27-$3.32.

• Rhode to contribute about 9 points to net sales growth in first four months; organic net sales expected up 4%-5%.

• Gross margin expected to be flat year-over-year at 71%, with tariff rates assumed at 35%.

• Adjusted EBITDA margin projected at 21%, up 20 basis points.

• Adjusted effective tax rate expected at 25–26%.